Jupiter Neurosciences, Inc. (NASDAQ:JUNS) Financings

Jupiter Neurosciences, Inc.

Financings

RaiseDate
Convertible Promissory Notes
Terms changed: US$6M
Buyers: Yorkville Advisors Global, LP (affiliate) ($6 million pre-paid advance, $4 million funded at signing); YA II PN, Ltd.
Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes
Feb 23, 2026
Common stock under standby equity purchase agreement
Announced: up to US$14M
Buyers: Yorkville Advisors Global, LP (affiliate) (up to $14 million of Common Stock over 24 months)
Use of proceeds: Phase 2 Parkinson's trial of JOTROL, Nugevia direct-to-consumer marketing and sales growth, working capital and general corporate purposes
Oct 27, 2025

Read by 6ix AI from the company's releases